Eamonn R. Maher, M.D., F.R.C.P., Birmingham, England

MAHER, Eamonn R., M.D., F.R.C.P., Professor of Medical Genetics, and Head Medical and Molecular Genetics, University of Birmingham, England. Dr. Maher was previously at Cambridge University. A graduate of the University of Manchester, Dr. Maher has a special interest in the clinical and molecular aspects of familial cancer syndromes, particularly von Hippel-Lindau disease.Dr. Maher and his colleagues provide a national service for advice on the clinical management and screening, and molecular genetic testing for VHL disease. He has participated in more than 100 scientific papers and is Editor-in-Chief of the Journal of Medical Genetics. Dr. Maher and his research group are investigating the molecular genetics and function of the VHL tumour suppressor gene.

His publications include "Clinical features and natural history of von Hippel-Lindau disease" (Quarterly J. Med 1990 70:1151-1163) , "Identification of the von Hippel-Lindau disease tumour suppressor gene" (Science 1993 260:1317-1320), and a book A Practical Guide to Human Cancer Genetics (with Dr. S. V. Hodgson, Cambridge University Press). Dr. Maher and his research group were actively involved in mapping and isolating the VHL gene and are continuing to investigate the molecular genetics of VHL disease.

Dr. Maher was a featured speaker at the Second International Patient/Provider meeting on von Hippel-Lindau in Boston, April 1995, and at the Symposia in Freiburg, Paris, and Rochester.

updated 31 January 2000

[VHLFA Home] [About VHL] [Managing Your Health] [Professional Info] [Research] [About VHLFA]

Click here to Donate safely online through our secure server